Neville Rodie & Shaw Inc Johnson & Johnson Transaction History

Neville Rodie & Shaw Inc

$1.36 Billion
Q3 2024

A detailed history of Neville Rodie & Shaw Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 180,768 shares of JNJ stock, worth $26.5 Million. This represents 2.16% of its overall portfolio holdings.

Number of Shares

180,768

Previous 188,976 4.34%

Holding current value

$26.5 Million

Previous $27.6 Million 6.06%

% of portfolio

2.16%

Previous 2.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$145.48 - $167.38 $1.19 Million - $1.37 Million	-8,208 Reduced 4.34%	180,768 $29.3 Million
Q2 2024 Jul 01, 2024	SELL	$144.38 - $157.78 $4.49 Million - $4.91 Million	-31,127 Reduced 14.14%	188,976 $27.6 Million
Q1 2024 Apr 09, 2024	SELL	$155.22 - $162.74 $813,197 - $852,594	-5,239 Reduced 2.32%	220,103 $34.8 Million
Q4 2023 Jan 02, 2024	SELL	$145.6 - $158.88 $545,854 - $595,641	-3,749 Reduced 1.64%	225,342 $35.3 Million
Q3 2023 Oct 10, 2023	SELL	$155.75 - $174.48 $184,719 - $206,933	-1,186 Reduced 0.52%	229,091 $35.7 Million
Q2 2023 Jul 06, 2023	SELL	$154.35 - $166.11 $486,974 - $524,077	-3,155 Reduced 1.35%	230,277 $38.1 Million
Q1 2023 Apr 04, 2023	SELL	$151.05 - $180.26 $422,033 - $503,646	-2,794 Reduced 1.18%	233,432 $36.2 Million
Q4 2022 Jan 03, 2023	BUY	$160.2 - $179.79 $14,417 - $16,181	90 Added 0.04%	236,226 $41.7 Million
Q3 2022 Oct 04, 2022	SELL	$161.33 - $179.52 $575,464 - $640,347	-3,567 Reduced 1.49%	236,136 $38.6 Million
Q2 2022 Jul 06, 2022	SELL	$168.19 - $186.01 $390,368 - $431,729	-2,321 Reduced 0.96%	239,703 $42.5 Million
Q1 2022 Apr 05, 2022	SELL	$158.14 - $179.59 $132,046 - $149,957	-835 Reduced 0.34%	242,024 $43.1 Million
Q4 2021 Jan 05, 2022	SELL	$155.93 - $173.01 $444,244 - $492,905	-2,849 Reduced 1.16%	242,859 $41.5 Million
Q3 2021 Oct 06, 2021	SELL	$161.5 - $179.47 $463,343 - $514,899	-2,869 Reduced 1.15%	245,708 $39.7 Million
Q2 2021 Jul 06, 2021	SELL	$159.48 - $171.07 $26,473 - $28,397	-166 Reduced 0.07%	248,577 $41 Million
Q1 2021 Apr 08, 2021	SELL	$153.07 - $170.48 $288,996 - $321,866	-1,888 Reduced 0.75%	248,743 $40.9 Million
Q4 2020 Mar 04, 2021	SELL	$137.11 - $157.38 $696,381 - $799,333	-5,079 Reduced 1.99%	250,631 $39.4 Million
Q3 2020 Oct 01, 2020	BUY	$140.38 - $153.83 $82,824 - $90,759	590 Added 0.23%	255,710 $38.1 Million
Q2 2020 Jul 15, 2020	SELL	$128.81 - $155.51 $339,543 - $409,924	-2,636 Reduced 1.02%	255,120 $35.9 Million
Q1 2020 Apr 01, 2020	SELL	$111.14 - $153.99 $152,261 - $210,966	-1,370 Reduced 0.53%	257,756 $33.8 Million
Q4 2019 Jan 08, 2020	BUY	$127.5 - $146.44 $444,082 - $510,050	3,483 Added 1.36%	259,126 $37.8 Million
Q3 2019 Oct 02, 2019	BUY	$126.95 - $142.14 $800,673 - $896,476	6,307 Added 2.53%	255,643 $33.1 Million
Q2 2019 Jul 01, 2019	SELL	$131.15 - $144.24 $935,492 - $1.03 Million	-7,133 Reduced 2.78%	249,336 $34.7 Million
Q1 2019 Apr 08, 2019	SELL	$125.72 - $139.79 $307,385 - $341,786	-2,445 Reduced 0.94%	256,469 $35.9 Million
Q4 2018 Jan 03, 2019	BUY	$122.84 - $147.84 $257,964 - $310,464	2,100 Added 0.82%	258,914 $33.4 Million
Q3 2018 Oct 09, 2018	SELL	$121.58 - $142.88 $328,022 - $385,490	-2,698 Reduced 1.04%	256,814 $35.5 Million
Q2 2018 Jul 03, 2018	SELL	$119.4 - $131.76 $571,329 - $630,471	-4,785 Reduced 1.81%	259,512 $31.5 Million
Q1 2018 Apr 12, 2018	BUY	$125.1 - $148.14 $197,032 - $233,320	1,575 Added 0.6%	264,297 $33.9 Million
Q4 2017 Jan 03, 2018	BUY	$131.22 - $143.62 $66,266 - $72,528	505 Added 0.19%	262,722 $36.7 Million
Q3 2017 Oct 03, 2017	BUY	$129.47 - $135.38 $33.9 Million - $35.5 Million	262,217	262,217 $34.1 Million

Others Institutions Holding JNJ

# of Institutions

4,276

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $383B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.

Account

Neville Rodie & Shaw Inc Johnson & Johnson Transaction History